Parisi, Valentina

Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue

Parisi, V., Petraglia, L., D'Esposito, V., Cabaro, S., Rengo, G., Caruso, A., Grimaldi, M. G., Baldascino, F., De Bellis, A., Vitale, D., et al. (2019) · International Journal of Cardiology

Cardiovascular Disease and AdiposityAtherosclerosis and Cardiovascular Diseases

Cited by 114

Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis

Myasoedova, V. A., Parisi, V., Moschetta, D., Valerio, V., Conte, M., Massaiu, I., Bozzi, M., Celeste, F., Leosco, D., Iaccarino, G., et al. (2023) · Cardiovascular Diabetology

Cardiovascular Disease and AdiposityAdipokines, Inflammation, and Metabolic Diseases

Cited by 93

The role of inflammation and metabolic risk factors in the pathogenesis of calcific aortic valve stenosis

Conte, M., Petraglia, L., Campana, P., Gerundo, G., Caruso, A., Grimaldi, M. G., Russo, V., Attena, E., Leosco, D., & Parisi, V. (2021) · Aging Clinical and Experimental Research

Cardiac Valve Diseases and TreatmentsCardiovascular Disease and Adiposity

Cited by 67

Anti-inflammation and anti-oxidation: the key to unlocking the cardiovascular potential of SGLT2 Inhibitors and GLP1 receptor agonists

Myasoedova, V. A., Bozzi, M., Valerio, V., Moschetta, D., Massaiu, I., Rusconi, V., Di Napoli, D., Ciccarelli, M., Parisi, V., Agostoni, P., et al. (2023) · Antioxidants

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 35

Sex-specific cell types and molecular pathways indicate fibro-calcific aortic valve stenosis

Myasoedova, V. A., Massaiu, I., Moschetta, D., Chiesa, M., Songia, P., Valerio, V., Alfieri, V., Capoulade, R., Trabattoni, D., Andreini, D., et al. (2022) · Frontiers in Immunology

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 32